Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,619 across all filing types
Latest filing 2014-08-13 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
103年第2季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement with detailed financial data for the second quarter and half-year periods of the fiscal years 2013 and 2014 (noted as 民國103年 and 102年). It includes revenue, costs, expenses, profit/loss, and earnings per share figures. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document length is 3571 characters, which is relatively short but contains detailed financial tables, not just an announcement or a link to a report. Therefore, it is not a Report Publication Announcement or Regulatory Filing. The content matches the definition of an Interim / Quarterly Report (IR). H1 2014
2014-08-13 Chinese
103年第2季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including asset, liability, and equity breakdowns. It includes actual financial figures and percentages, indicating substantive financial information rather than a mere announcement or summary. The presence of quarterly dates (e.g., 103年06月30日, which corresponds to the second quarter of the fiscal year) and detailed financial statement items confirms this is a financial report for a period shorter than a full fiscal year. The document length is under 5,000 characters but contains actual financial data, so it is not a report publication announcement. There is no indication that this is an annual report or audit report, and the detailed financial data aligns with an Interim / Quarterly Report. Q2 2014
2014-08-13 Chinese
103年第2季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed tables of changes in consolidated equity for two half-year periods (民國103年上半年度 and 民國102年上半年度), showing components such as common stock, capital surplus, legal surplus reserve, special surplus reserve, undistributed earnings, retained earnings, foreign currency translation adjustments, unrealized gains/losses on available-for-sale financial assets, treasury stock, and total equity attributable to the parent company and non-controlling interests. The data is presented in a financial statement format with monetary units and accounting items, indicating it is a financial report covering a period shorter than a full fiscal year. The presence of actual financial data and analysis for a half-year period aligns with the definition of an Interim / Quarterly Report (IR). The document length is under 5,000 characters but contains substantive financial data, so it is not merely an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2014
2014-08-13 Chinese
103年第2季大陸投資
Regulatory Filings Classification · 95% confidence The document is a tabular disclosure of investment information related to investments in mainland China by a Taiwanese listed company. It includes details such as investment amounts, capital, investment methods, and recognized investment gains or losses for a specific fiscal period (Year 103, Quarter 2). The content is financial and regulatory in nature but does not contain a full financial report or comprehensive financial statements. It appears to be a regulatory disclosure related to investment activities rather than a full annual or interim report. The document length is short (1292 characters), and it is a specific regulatory disclosure rather than a report or announcement of a report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2014-08-13 Chinese
公告本公司第二屆薪資報酬委員會委員
Board/Management Information Classification · 95% confidence The document is a short announcement (778 characters) about the appointment of members to the company's Compensation Committee, including names, titles, and effective dates. It does not contain financial data, audit information, or detailed reports. It is an announcement related to changes in company management or committees. Therefore, it fits the category of Board/Management Information (MANG).
2014-08-12 Chinese
公告本公司103年8月12日董事會通過之重要議案
Regulatory Filings Classification · 95% confidence The document is a short announcement from the company 景岳生物科技股份有限公司 dated 103/08/12 (Taiwan calendar year, equivalent to 2014) reporting that the board of directors approved the company's consolidated financial report for the first half of the year and the appointment of a remuneration committee. The document is only 641 characters long and does not contain the actual financial statements or detailed financial data, but rather announces the approval of the half-year financial report. According to the 'Menu vs Meal' rule, this is an announcement of a report approval, not the report itself. Therefore, it should be classified as a Regulatory Filing (RNS) rather than an Interim/Quarterly Report (IR).
2014-08-12 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.